New osteoporosis drug shows promise in Head-to-Head trial
NCT ID NCT05405725
First seen Feb 21, 2026 · Last updated May 24, 2026 · Updated 11 times
Summary
This study tested a new drug called Enzene denosumab (ENZ215) against the approved drug Prolia in 504 postmenopausal women with osteoporosis. The goal was to see if the new drug works as well at increasing bone density and reducing bone breakdown over 12 months. Both drugs are given as injections and aim to strengthen bones and prevent fractures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTMENOPAUSAL OSTEOPOROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centrum Medyczne Kuba- Med
Zamość, Poland
-
Centrum Medyczne Pratia Czestochowa
Częstochowa, Poland
-
Centrum Medyczne Pratia Gdynia
Gdynia, Poland
-
Clinic
Prague, 14800, Czechia
-
Clinical Hospital Centre Bezanijska Kosa
Zemun, Serbia
-
DCC XVII-Sofia EOOD
Sofia, 1505, Bulgaria
-
ETG Kielce, ul. Zagorska
Kielce, Poland
-
ETG Lodz, ul. Pilota Stanislawa Wigury
Lodz, Poland
-
ETG Lublin, ul. Kunickiego
Lublin, Poland
-
ETG Siedlce
Siedlce, Poland
-
Fakultni nemocnice v Motole
Prague, Czechia
-
G-CENTRUM Olomouc
Horní Město, Czechia
-
Hospital de La Santa Creu i Sant Pau
Barcelona, Spain
-
Hospital of Lithuanian University of Health Sciences Kauno klinikos
Kaunas, 50161, Lithuania
-
Institute for Rheumatology
Belgrade, Serbia
-
Institute for Treatment and Rehabilitation Niska Banja
Niška Banja, Serbia
-
JSC Saules seimos medicinos ce
Kaunas, 49449, Lithuania
-
Kaunas City Polyclinic
Kaunas, 51270, Lithuania
-
Krakowskie Centrum Medyczne
Krakow, Poland
-
Lithuanian University of Health Sciences Hospital
Kaunas, Lithuania
-
MEDICAL PLUS s.r.o.
Uherské Hradiště, Czechia
-
Medical Center Teodora,
Rousse, 7000, Bulgaria
-
National Osteoporosis Center
Vilnius, 09310, Lithuania
-
Osteo-Medic S.C. A Racewicz
Bialystok, Poland
-
Prywatna Praktyka Lekarska
Poznan, Poland
-
Republican Siauliai Hospital
Šiauliai, Lithuania
-
Research Center
Brno, 60200, Czechia
-
Research Center
Pardubice, Czechia
-
Research Center(Medical Center Synexus Sofia EOOD)
Sofia, 1784, Bulgaria
-
Silmedic sp. z o.o.,ul. Gen. Wladyslawa Sikorskiego
Katowice, Poland
-
Sydvestjysk Sygehus Esbjerg
Esbjerg, 6700, Denmark
-
Synexus Czech
Prague, 12000, Czechia
-
Synexus Polska
Częstochowa, Poland
-
Synexus Polska
Gdansk, Poland
-
Synexus Polska
Gdynia, Poland
-
Synexus Polska
Katowice, Poland
-
Synexus Polska
Lodz, Poland
-
Synexus Polska
Poznan, Poland
-
Synexus Polska
Warsaw, Poland
-
Synexus Polska
Wroclaw, Poland
-
Szpital Uniwersytecki
Bydgoszcz, Poland
-
Twoja Przychodnia - Szczecinskie Centrum Medyczne
Szczecin, Poland
-
Twoja Przychodnia Nowosolskie Centrum Medyczne,
Nowa Sól, Poland
-
Twoja Przychodnia PCM
Poznan, Poland
-
University Hospital
Plovdiv, 4027, Bulgaria
-
University Hospital.
Pilsen, Czechia
-
Vilnius University Hospital Santaros Klinikos
Vilnius, 08661, Lithuania
-
Zvezdara University Medical Center
Belgrade, Serbia
Conditions
Explore the condition pages connected to this study.